OTCMKTS:ABCZF

Abcam - ABCZF Stock Forecast, Price & News

15.36

-0.04 (-0.23%)

(As of 12/8/2022 09:02 PM ET)

Add

Compare

Today's Range: 15.15
▼
15.36
50-Day Range: 14.51
▼
17.04
52-Week Range: 12.86
▼
23.08

Volume: 600 shs
Average Volume: 3,774 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Abcam (OTCMKTS:ABCZF) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABCZF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCZF Stock News Headlines

December 6, 2022 | americanbankingnews.com

Abcam plc (OTCMKTS:ABCZF) Sees Large Decrease in Short Interest

July 13, 2022 | benzinga.com

Abcam (OTC:ABCZF), Short Interest Report

July 12, 2022 | benzinga.com

Abcam (OTC:ABCZF), Earnings Estimates, EPS, and Revenue

May 20, 2022 | uk.finance.yahoo.com

Which way now for the Abcam share price?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ABCZF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ABCZF
CUSIP: N/A
CIK: 1492074
Web: abcam.com
Phone: 441223696000
Fax: N/A
Employees: 1,650
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Alan Thomas Hirzel BS (Age 54)
M.B.A., M.S., MBA, MS, CEO & Exec. Director
Comp: $1.47M

Mr. Michael Shaun Baldock B.A. (Age 58)
CFO & Director
Comp: $1.05M

Mr. Mark Dermody
Interim CIO

James Staveley
VP of Investor Relations

Marc Perkins
Gen. Counsel & Company Sec.

Emma Sceats
Sr. VP of Sales, Service & Bus. Devel.

Mr. Nick Skinner
Sr. VP of HR

Mr. Mark Bushfield
Sr. VP of Research & Innovation

Ms. Kirstie Speck BBusSc
Head of Consumer Insights

Ms. Yvonne Chien
Sr. VP of Customer Experience

Key Competitors

View All Competitors

ABCZF Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ABCZF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCZF, but not buy additional shares or sell existing shares.
View ABCZF analyst ratings or view top-rated stocks.
How have ABCZF shares performed in 2022?: Abcam's stock was trading at 16.37 at the start of the year. Since then, ABCZF shares have decreased by 6.0% and is now trading at 15.40.
View the best growth stocks for 2022 here.
Are investors shorting Abcam?: Abcam saw a decrease in short interest in November. As of November 15th, there was short interest totaling 371,900 shares, a decrease of 9.5% from the October 31st total of 410,900 shares. Based on an average daily volume of 3,200 shares, the days-to-cover ratio is currently 116.2 days.
View Abcam's Short Interest.

What is Abcam's stock symbol?: Abcam trades on the OTCMKTS under the ticker symbol "ABCZF."
How do I buy shares of Abcam?: Shares of ABCZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Abcam's stock price today?: One share of ABCZF stock can currently be purchased for approximately 15.40.
How many employees does Abcam have?: The company employs 1,650 workers across the globe.
How can I contact Abcam?: Abcam's mailing address is Discovery Drive, Cambridge, East Anglia. The official website for the company is abcam.com. The company can be reached via phone at 441223696000.

This page (OTCMKTS:ABCZF) was last updated on 12/9/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial